共 50 条
- [31] Cardiovascular Safety Findings In Rheumatoid Arthritis Patients Treated With Tofacitinib, A Novel, Oral Janus Kinase Inhibitor ARTHRITIS AND RHEUMATISM, 2013, 65 : S191 - S191
- [34] Tofacitinib, an Oral Janus Kinase Inhibitor: Pooled Efficacy and Safety Analyses in an Australian Rheumatoid Arthritis Population Rheumatology and Therapy, 2018, 5 : 383 - 401
- [40] Topical Tofacitinib: A Janus Kinase Inhibitor for the Treatment of Vitiligo in an Adolescent Patient CASE REPORTS IN DERMATOLOGY, 2021, 13 (01): : 190 - 194